AMERISOURCEBERGEN DRUG CORPORATION (CAGE 1XUY5, UEI KABZK8W6PQT3) has received nearly all of its federal obligation volume from the Defense Logistics Agency, which accounts for $31.86 billion across 3,690,627 actions. Smaller awards appear from the Office of Assistant Secretary for Preparedness and Response, the National Institutes of Health, the Department of Veterans Affairs, and the Indian Health Service.
Federal Contractor
AMERISOURCEBERGEN DRUG CORPORATION Federal Contract Obligations (Last 10 Years)
AMERISOURCEBERGEN DRUG CORPORATION's federal procurement record over the last 10 years shows 3,690,767 award actions totaling $31.98 billion, led overwhelmingly by the Defense Logistics Agency.
Totals and trends reflect readable FPDS obligation data for the last 10 years and may vary slightly from exact sums due to rounding.
CAGE Code
1XUY5
UEI
KABZK8W6PQT3
Total Obligated
31.98 billion
31,983,814,743.16
Award Actions
3,690,767
Average Action Value
8,665.89
About AMERISOURCEBERGEN DRUG CORPORATION federal contract activity
AMERISOURCEBERGEN DRUG CORPORATION recorded $31.98 billion in FPDS-obligated awards across 3,690,767 actions over the last 10 years, with an average award value of $8,665.89. The profile is highly action-heavy and dollar-concentrated, indicating repeated ordering activity rather than a small number of large transactions.
Agency mix and customer concentration
The award base is overwhelmingly concentrated in the DEFENSE LOGISTICS AGENCY, which accounts for $31.86 billion and 3,690,627 awards, or nearly the entire observed volume. Secondary activity is limited and much smaller, led by the Office of Assistant Secretary for Preparedness and Response, National Institutes of Health, the Department of Veterans Affairs, and Indian Health Service.
Industry profile based on NAICS activity
The vendor’s obligations split primarily between 325411 Medicinal and Botanical Manufacturing and 424210 Drugs and Druggists' Sundries Merchant Wholesalers, which together represent nearly all observed dollars and awards. Smaller amounts appear in refrigerated warehousing and storage, pharmaceutical preparation manufacturing, and in-vitro diagnostic substance manufacturing, suggesting supporting logistics and adjacent pharmaceutical supply categories.
Annual contract trend over the analysis window
Annual obligations accelerated sharply in the most recent years shown, rising from $2.04 billion in 2021 and $2.08 billion in 2022 to $5.14 billion in 2023, $6.51 billion in 2024, and $7.36 billion in 2025. Award counts remained consistently high, with roughly 360,000 to 499,000 actions per year in the 2021-2025 period.
How to interpret this page
This summary is based on FPDS-award activity for AMERISOURCEBERGEN DRUG CORPORATION, matched to CAGE 1XUY5 and UEI KABZK8W6PQT3, over the last 10 years. Totals reflect obligated dollars and award counts as provided in the supplied dataset; category rankings are based on the top agencies, NAICS codes, and annual totals included here.
Top Agencies
SELECT
agency_id,
agency_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '1XUY5'
AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10| Agency ID | Agency Name | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 97AS | DEFENSE LOGISTICS AGENCY | 31,859,976,051.50 | 31.86 billion | 3,690,627 |
| 7505 | OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE | 61,866,608.56 | 61.87 million | 11 |
| 7529 | NATIONAL INSTITUTES OF HEALTH | 48,623,557.04 | 48.62 million | 109 |
| 3600 | VETERANS AFFAIRS, DEPARTMENT OF | 6,803,653.78 | 6.80 million | 13 |
| 7527 | INDIAN HEALTH SERVICE | 6,416,080.00 | 6.42 million | 1 |
| 1549 | FEDERAL BUREAU OF INVESTIGATION | 104,912.28 | 104.91 thousand | 5 |
| 1540 | FEDERAL PRISON SYSTEM / BUREAU OF PRISONS | 23,880.00 | 23.88 thousand | 1 |
Insight
Over the last 10 years, AMERISOURCEBERGEN DRUG CORPORATION’s federal obligations are overwhelmingly concentrated at the Defense Logistics Agency, which accounts for $31.86 billion of the $31.98 billion total and 3,690,627 of 3,690,767 awards. The remaining agencies represent a very small share of spend, with the next largest obligations at the Office of Assistant Secretary for Preparedness and Response ($61.87 million) and the National Institutes of Health ($48.62 million). This pattern indicates a highly concentrated procurement profile with limited but recurring activity across a small number of civilian and medical agencies.
Top NAICS
SELECT
naics_code,
naics_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '1XUY5'
AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
AND content__award__productOrServiceInformation__principalNAICSCode != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10| NAICS Code | Description | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 325411 | MEDICINAL AND BOTANICAL MANUFACTURING | 16,449,851,175.95 | 16.45 billion | 1,190,918 |
| 424210 | DRUGS AND DRUGGISTS' SUNDRIES MERCHANT WHOLESALERS | 15,410,051,680.60 | 15.41 billion | 2,499,813 |
| 493120 | REFRIGERATED WAREHOUSING AND STORAGE | 59,916,108.56 | 59.92 million | 9 |
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | 59,647,437.05 | 59.65 million | 19 |
| 325413 | IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING | 4,321,661.00 | 4.32 million | 5 |
| 561320 | TEMPORARY HELP SERVICES | 23,880.00 | 23.88 thousand | 1 |
| 334220 | RADIO AND TELEVISION BROADCASTING AND WIRELESS COMMUNICATIONS EQUIPMENT MANUFACTURING | 2,800.00 | 2.80 thousand | 2 |
Insight
AMERISOURCEBERGEN DRUG CORPORATION’s obligations over the last 10 years are highly concentrated in two NAICS codes: 325411 (Medicinal and Botanical Manufacturing) and 424210 (Drugs and Druggists' Sundries Merchant Wholesalers), which together account for essentially all of the $31.98 billion obligated and the vast majority of the 3.69 million awards. NAICS 325411 is the largest category by dollars at $16.45 billion, while NAICS 424210 is the largest by award volume at 2.50 million awards and $15.41 billion obligated. All remaining NAICS codes are comparatively immaterial, each contributing less than $60 million and fewer than 20 awards except 493120, which reflects 9 awards totaling $59.92 million.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '1XUY5'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 10 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | 7,356,172,923.48 | 7.36 billion | 497,767 |
| 2024 | 6,505,686,800.84 | 6.51 billion | 498,540 |
| 2023 | 5,139,371,927.44 | 5.14 billion | 486,228 |
| 2022 | 2,083,328,622.51 | 2.08 billion | 390,402 |
| 2021 | 2,037,831,307.75 | 2.04 billion | 359,893 |
| 2020 | 2,147,558,161.81 | 2.15 billion | 359,861 |
| 2019 | 2,351,200,211.67 | 2.35 billion | 404,544 |
| 2018 | 2,304,420,062.73 | 2.30 billion | 384,240 |
| 2017 | 2,058,072,144.51 | 2.06 billion | 309,117 |
| 2016 | 172,580.42 | 172.58 thousand | 175 |
Insight
AMERISOURCEBERGEN DRUG CORPORATION (CAGE 1XUY5) obligated $31.98 billion across 3,690,767 awards over the last 10 years, with a relatively low average award value of $8,665.89, indicating a high-volume, low-dollar transaction profile. Obligations are heavily concentrated in the most recent three years, rising from $5.14 billion in 2023 to $6.51 billion in 2024 and $7.36 billion in 2025, after a lower but still substantial band of roughly $2.0 billion to $2.4 billion annually from 2017 through 2022. The 2016 activity is immaterial by comparison at $172.58 thousand across 175 awards, suggesting a sharp ramp-up in later years.
Use FPDS Query for deeper contractor analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper contractor analysis across buying agencies, NAICS, and annual trends.
Continue from this last 10 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.